Cargando…

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Baumert, Thomas F., Hoshida, Yujin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563310/ https://www.ncbi.nlm.nih.gov/pubmed/31096600 http://dx.doi.org/10.3390/v11050441

Ejemplares similares

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
por: Rocha, Chiara, et al.
Publicado: (2023)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
por: Li, Shen, et al.
Publicado: (2020)

Hepatitis C: the challenges to link patients to the cure
Publicado: (2019)

Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
por: Kubota, Naoto, et al.
Publicado: (2020)

Memories of Stress: The Imprinted Cancer Risk After HCV Cure
por: Lupberger, Joachim, et al.
Publicado: (2023)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
por: Kim, Myung‐Ho, et al.
Publicado: (2022)

Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
por: Li, Shen, et al.
Publicado: (2018)

The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
por: Aleman, Soo
Publicado: (2016)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
por: Lee, Chang Hun, et al.
Publicado: (2021)

Successes and Challenges on the Road to Cure Hepatitis C
por: Horner, Stacy M., et al.
Publicado: (2015)

Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis
por: Venkatesh, Anu, et al.
Publicado: (2014)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C
por: Perumalswami, Ponni V., et al.
Publicado: (2022)

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure
por: Polyak, Stephen J., et al.
Publicado: (2021)

Challenges for addressing dementia
por: The Lancet Regional Health – Europe
Publicado: (2022)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
por: Jang, Byoung Kuk
Publicado: (2016)

Effects of Continuous Hepatitis with Persistent Hepatitis C Viremia on Outcome after Resection of Hepatocellular Carcinoma
por: Kubo, Shoji, et al.
Publicado: (1999)

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Editorial: Addressing the persistent epidemic of violence against nurses
por: Oerther, Sarah, et al.
Publicado: (2021)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence
por: Ke, Ruian, et al.
Publicado: (2018)

HIV cure research: a formidable challenge
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
por: Piñero, Federico, et al.
Publicado: (2018)

The clinical management of hepatocellular carcinoma in China: Progress and challenges
por: Shan, Shan, et al.
Publicado: (2023)

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jruq4pq9dbkusskdpggs4n9q28